17-GMB-APA-GA Unit size Cat. code Docs Qty Price
Geldanamycin Analog for Conjugation to a Monoclonal Antibody
1 mg

A geldanamycin analog for conjugation to a monoclonal antibody

17-GMB-APA-GA is a maleimido derivative of geldanamycin that enables the conjugation of GA to a monoclonal antibody (mAb) such as Herceptin, the first mAb approved for therapy of solid tumors.

This geldanamycin immunoconjugate induces less systemic toxicity than GA by being selectively delivered into malignant cells, a property conferred by the mAb that acts as the targeting vehicle.

NCI has reported that Herceptin-GA conjugates deliver a more potent selective cytotoxic impact to Her2-overexpressing tumors than Herceptin alone [1]. To prepare such conjugates, GA is modified to introduce a latent primary amine [2].

After deprotection, this primary amine provides a site for introduction of a maleimide group that enables linkage to proteins.


1. Mandler R. et al., 2004. Herceptin-geldanamycin immunoconjugates: pharmacokinetics, biodistribution, and enhanced antitumor activity. Cancer Res. 64(4):1460-7.
2. Mandler R. et al., 2002. Modifications in synthesis strategy improve the yield and efficacy of geldanamycin-herceptin immunoconjugates. Bioconjug Chem. 13(4):786-91.

Back to the top


Formula: C39H53N5O11

Molecular weight: 768

Solubility: DMSO (10 mg/ml)

Back to the top


  • 1 mg

room temperature 17-GMB-APA-GA is shipped at room temperature.

store Store lyophilized product at -20°C in the dark.

Alert Protect from light.

stable Lyophilized productis stable for 6 months when stored properly.

Back to the top

Customer Service
& Technical Support

In order to prevent automated spam submissions, please answer the following question:
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Shopping cart is empty